Venus Remedies Ltd

NSE: VENUSREM · BSE: 526953 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹1,769.40
Market cap: ₹2,365 Cr
Revenue (annual): ₹769.6 Cr
Net profit (annual): ₹102.8 Cr
P/E (TTM): 20.4×Sector 47.3×
Promoter holding: 41.76%+0.00% QoQ
FII holding: 2.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 7 Financial Results 4 Management Change 2 Annual General Meeting 2 Regulatory Approval 1 Dividend 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 May 2026 22:37 IST NSE

Board Meeting Outcome

Venus Remedies Board Meeting Outcome

Venus Remedies approved several board appointments, including Saransh Chaudhary as Executive Director. These leadership changes aim to strengthen governance and strategic oversight for five-year terms.

Read the filing ↗